News & Events

Using Osmolality to Diagnose and Treat Hyponatremia in COVID-19 Patients | A Scientific Resource from Advanced Instruments

May 13, 2020

OSMOLALITY TESTING CAN HELP WITH EARLY DIAGNOSIS AND ETIOLOGICAL DETERMINATION OF HYPONATREMIA, WHICH IS CRITICAL FOR THIS PATIENT POPULATION.  

<<DOWNLOAD THE FULL SCIENTIFIC RESOURCE>>  Article Summary: Recent publications have shown that COVID-19 (coronavirus disease 2019), an infectious disease caused by a novel coronavirus known as severe acute respiratory syndrome coronavirus (SARS-CoV-2), is associated with electrolyte disorders including hyponatremia. Early diagnosis and etiologic determination are critical in any hyponatremic patient to ensure proper treatment and to avoid potential harm to the patient. Osmolality testing is quick, inexpensive and effective to help with early detection and diagnosis of hyponatremia. Osmolality testing can help ensure that appropriate treatment strategies are implemented early for hyponatremic patients which may be even more significant in patients hospitalized with COVID-19. As clinicians and researchers continue to expand their understanding of COVID-19, additional laboratory testing is important to consider to help better understand and diagnose a COVID-19 patient’s underlying conditions.

 

 

For inquiries, please contact:

Lisa Fahey, Director of Marketing, [email protected]

Advanced Instruments

2 Technology Way

Norwood, MA 02062

800-225-4034

Related News & Events

News

Maximizing Cloning Success: Combining Automation with Cell Supplements for the Best Results

VIEW

News

New Knowledge Center Article - Imaging Complex Cell Morphology: Mesenchymal Stem Cells (MSCs)

VIEW

News

AI and Robotics in Cell Line Development: Enhancing Efficiency and Accuracy, Upcoming Webinar Hosted by Xtalks

VIEW